Mark Andrew Miller

Title: Mark Andrew Miller: Innovator in Protein Research

Introduction

Mark Andrew Miller is a notable inventor based in Wyndmoor, Pennsylvania. He has made significant contributions to the field of protein research, holding a total of 2 patents. His work focuses on novel proteins and their applications in immunology.

Latest Patents

Miller's latest patents include innovative developments in protein SA1789. This invention provides the SA1789 protein, along with nucleic acid and nucleic acid sequence homologues encoding this protein. Additionally, it features a composition, particularly a vaccine, that comprises the SA1789 protein or its fragments, which are capable of generating an immune response that leads to the killing and clearance of targeted pathogens. Another patent highlights polypeptides that comprise an amino acid sequence structurally related to SEQ ID NO: 1, including AhpC-AhpF compositions. This invention demonstrates the potential of these polypeptides and compositions in producing a protective immune response.

Career Highlights

Mark Andrew Miller is associated with Merck Sharp & Dohme Corporation, where he continues to advance his research in protein innovations. His work has been instrumental in developing new therapeutic approaches.

Collaborations

Miller collaborates with talented colleagues, including Tessie Brown McNeely and Rosemarie Kelly, who contribute to his research endeavors.

Conclusion

Mark Andrew Miller's contributions to protein research and his innovative patents underscore his role as a significant inventor in the field. His work continues to pave the way for advancements in immunology and therapeutic applications.